Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides.
about
Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionType AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structure-activity relationships and mode of actionNano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria.Lipid-II forms potential "landing terrain" for lantibiotics in simulated bacterial membrane.High divergence of the precursor peptides in combinatorial lanthipeptide biosynthesis.Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in actinobacteriaPhosphoserine Lyase Deoxyribozymes: DNA-Catalyzed Formation of Dehydroalanine Residues in Peptides.Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.An engineered lantibiotic synthetase that does not require a leader peptide on its substrate.The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry.Biomedical applications of nisin.Leader Peptide Establishes Dehydration Order, Promotes Efficiency, and Ensures Fidelity During Lacticin 481 Biosynthesis.Chemical synthesis of the lantibiotic lacticin 481 reveals the importance of lanthionine stereochemistry.A general method for fluorescent labeling of the N-termini of lanthipeptides and its application to visualize their cellular localization.The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.Recent derivatives from smaller classes of fermentation-derived antibacterials.Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.Increasing the success rate of lantibiotic drug discovery by Synthetic Biology.Novel avenues for Clostridium difficile infection drug discovery.Developing new antibacterials through natural product research.Cu-mediated enamide formation in the total synthesis of complex peptide natural products.Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.Cysteine-rich low molecular weight antimicrobial peptides from Brevibacillus and related genera for biotechnological applications.Synthesis of nisin AB dicarba analogs using ring-closing metathesis: influence of sp(3) versus sp(2) hybridization of the α-carbon atom of residues dehydrobutyrine-2 and dehydroalanine-5 on the lipid II binding affinity.In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificitySynthesis and structural characterization of the individual diastereoisomers of a cross-stapled alkene-bridged nisin DE-ring mimic.Incorporation of Nonproteinogenic Amino Acids in Class I and II Lantibiotics.Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection.OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.High-resolution NMR studies of antibiotics in cellular membranes
P2860
Q26748638-BC173B4D-58E7-4A68-9591-DEE4A10DF61CQ27690184-82987B42-3919-4BFE-BBB4-F30E83656F48Q33849047-2AED73EE-EEE0-4BF2-9E54-B12113FD380CQ34339406-3543A309-A3EE-47E2-9CEE-CD4FBEEB5280Q34576266-45BD2071-1CD0-4813-9B34-A6FA3351FDA9Q35764125-32E8892E-9942-4A42-96A3-BD7A661CF346Q35925245-14C92A92-F806-4172-8985-E62871B4F8CCQ35949915-8609BC73-2144-4E22-8B16-2E7B425A9C2DQ35952908-0D8A88B4-80AA-4555-9466-D08D9C6634D9Q36625577-DEDDDB2A-39B3-4BAD-BDBF-AFD1823354FDQ36900890-E1EF54B3-D18B-46DD-9F70-E343E263EC5AQ36936118-11862EA2-1044-4A4E-B5E4-FD52ACBF44FAQ37078724-F9231564-6DD9-431F-BB31-1FD19E2A31BDQ37177787-99B08526-D92D-46C9-817B-067257ED48F1Q37203727-C77F2F0C-2D4F-44B5-8CE5-C0FC5CFB2530Q37940910-BF56E463-8E2D-4B9E-A6C6-CE73D7462C99Q37964009-8CEE583C-68DD-4EB9-A4D3-584D715AA2E1Q38009935-639BD07F-9E26-49D1-BB3D-F58E2FEC4138Q38017216-7133A50A-5AA7-44A2-A478-1A939DCFA277Q38083297-267669F4-ADE0-49B1-9743-C5D15A2374A1Q38088256-9C48F59C-ECAD-4154-A330-DB3FCDF570A4Q38190893-5BADC1C8-9919-40CE-AC67-16F5962E6B12Q38701785-A4C41C10-2F58-4803-95B9-4CC5C33F94AFQ39109460-127DEC60-8F4C-4BCF-8D07-C5203B680007Q39324024-A3CFD395-C941-4004-AA88-4FD57C9EBA8CQ40977609-CAF081E1-6606-498B-A1D1-149041464AC5Q41184618-EFC93728-8F7B-4D06-A30B-FAD9D908E0F3Q42167889-F1AD2B51-F5ED-48BB-B0CB-1B42D03407D9Q46075143-03FDEB80-797E-4203-9A07-1DFB17855CFEQ50033661-92D6B0A0-0ABD-4118-983F-EB9E78E28351Q52608578-BC186774-BF39-4CDF-A0A2-87720C357B17Q55307893-64E928A8-85B2-4C48-AECE-A9D820CEAF36Q57560677-4D06DE68-78C0-4B57-88DF-02D114CAAE66
P2860
Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@en
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@nl
type
label
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@en
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@nl
prefLabel
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@en
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@nl
P2860
P356
P1476
Fundamental functionality: rec ...... ships of lantibiotic peptides.
@en
P2093
Avena C Ross
P2860
P2888
P356
10.1038/JA.2010.136
P577
2010-11-17T00:00:00Z
P5875
P6179
1037072964